Literature DB >> 9459195

hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro.

C M Klinge1, C L Brolly, R A Bambara, R Hilf.   

Abstract

Bovine estrogen receptor (ER) was purified to near homogeneity by estrogen response element (ERE) affinity chromatography, and its ERE binding ability was measured in vitro. Highly purified ER bound EREs with reduced affinity compared to partially purified ER. Partially purified ER contained hsp70, but highly purified ER did not. We examined whether addition of purified recombinant human hsp70 or purified bovine hsp70 would restore the higher ERE binding affinity, stoichiometry, and ligand retention detected with partially purified receptor and how hsp70 affected the rate of ER-ERE association and dissociation. ER-ERE binding was not affected by antibodies to either constitutive or induced forms of hsp70, regardless of ER purity. Addition of purified hsp70, with or without ATP and Mg2+, did not affect the association or dissociation rates of highly purified liganded ER binding to ERE. hsp70 Did not alter the total amount of ER-ERE complex formed. Similarly, hsp70 did not affect the rate of [3H]estradiol (E2) or [3H]4-hydroxytamoxifen (4-OHT) ligand dissociation from ER in the presence or absence of EREs. These data contrast with a report showing that maximal ERE binding by highly purified recombinant human ER required hsp70. We conclude that ER, purified from a physiological source, i.e., calf uterus, does not require hsp70 for maximal ER-ERE binding in vitro. Additionally, once ER is activated and bound by ligand, the receptor assumes its proper tertiary structure, and hsp70 does not impact ER ligand binding domain conformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9459195     DOI: 10.1016/s0960-0760(97)00091-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  6 in total

1.  Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.

Authors:  Mary D Chamberlin; Jason D Wells; Kevin Shee; Jennifer R Bean; Jonathan D Marotti; Wendy A Wells; Heidi W Trask; Fred W Kolling; Ananta Bhatt; Peter A Kaufman; Gary N Schwartz; John M Gemery; Nancy J McNulty; Michael J Tsapakos; Richard J Barth; Bradley A Arrick; Jiang Gui; Todd W Miller
Journal:  Breast Cancer Res Treat       Date:  2020-06-19       Impact factor: 4.872

Review 2.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

3.  Effect of prenatal exposure to lead on estrogen action in the prepubertal rat uterus.

Authors:  Andrei N Tchernitchin; Leonardo Gaete; Rodrigo Bustamante; Aracelly Báez
Journal:  ISRN Obstet Gynecol       Date:  2012-01-02

4.  Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ERα) and Biochemical Characterization of the ERα-Hsp70 Interaction.

Authors:  Ahmed E Dhamad; Zhenqi Zhou; Jianhong Zhou; Yuchun Du
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

Review 5.  The emerging role of estrogen related receptorα in complications of non-small cell lung cancers.

Authors:  Tapan K Mukherjee; Parth Malik; John R Hoidal
Journal:  Oncol Lett       Date:  2021-02-04       Impact factor: 2.967

Review 6.  Sex differences in vulnerability to addiction.

Authors:  Jacqueline A Quigley; Molly K Logsdon; Christopher A Turner; Ivette L Gonzalez; N B Leonardo; Jill B Becker
Journal:  Neuropharmacology       Date:  2021-02-07       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.